Blueprint Medicines Reports First Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. SMCI
8. RTX
9. S
10. COF

Go back to Blueprint Medicines Reports First Quarter 2019 Financial Results

Blueprint Medicines (BPMC) Misses Q1 EPS by 12c

May 9, 2019 7:18 AM EDT

Blueprint Medicines (NASDAQ: BPMC) reported Q1 EPS of ($1.98), $0.12 worse than the analyst estimate of ($1.86).

Financial Guidance:

Based on its current plans, Blueprint Medicines expects that its existing cash, cash equivalents and investments, including the estimated net proceeds of approximately $327.2 million from its April... More